LEIGH CATALDO: Open Payments
NPI 1154434421 · SAN DIEGO, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$315 in 15 payments from 8 companies in 2025. Trend: 2023 $129 · 2024 $412 · 2025 $315
Food & beverage: $315
| Company | Payments | Amount |
|---|---|---|
| Astellas Pharma US Inc | 3 | $84 |
| MAYNE PHARMA COMMERCIAL LLC | 5 | $65 |
| MILLICENT US INC | 2 | $42 |
| VERTEX PHARMACEUTICALS INCORPORATED | 1 | $35 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $24 |
| Biogen, Inc. | 1 | $24 |
| Medtronic, Inc. | 1 | $22 |
| Evofem Biosciences, Inc. | 1 | $19 |
Products named: Veozah, FEMLYV, JOURNAVX, Mirena, ZURZUVAE, SYMPLICITY G3, Phexxi.
Industry payments across CA — which companies pay providers there.
